METABOLIC RESEARCH
TIRZEPATIDE
10MG · LYOPHILIZED
Tirzepatide is a dual GIP/GLP-1 receptor agonist used as a reference compound in laboratory metabolic research.
A dual GIP and GLP-1 receptor agonist used as a reference compound in laboratory metabolic research. Research interest includes incretin-pathway studies, energy-balance research, glycemic-marker research models, and gastric-motility research. For laboratory research use only.
Use code FIRST10 for 10% OFF at checkout
Save more with box purchases. Add 9 more to unlock 20% off this vial.
Wholesale pricing available for schools, clinics, and repeat customers. Request a quote →
- PURITY
- ≥99.2%
- CAS NUMBER
- 2023788-19-2
- APPEARANCE
- Lyophilized white powder
- SHELF LIFE
- 24 months unopened. 30 days reconstituted (refrigerated).
- STORAGE
- Store at 2–8°C, protected from light. Long-term: -20°C.
- RECONSTITUTION
- Reconstitute with 1 mL bacteriostatic water (0.9% benzyl alcohol).
OUT OF STOCK — JOIN BATCH WAITLIST
Get notified the moment this batch is restocked. We'll only email you about TIRZEPATIDE 10MG.
QUALITY VERIFIED
PREMIUM PACKAGING
DISCREET SHIPPING
SECURE CHECKOUT
Encrypted payments & private order details
RESEARCH-GRADE QUALITY
≥99% HPLC purity across the catalog
THIRD-PARTY TESTED
Independently verified by Janoshik Analytical
DISCREET SHIPPING
Sealed, unbranded, tracked worldwide
GLOBAL FULFILLMENT NETWORK
Global Fulfillment Network
Fast, secure, and discreet fulfillment through our Canada and Philippines distribution network.
Product Information
- Compound: TIRZEPATIDE
- Dosage: 10MG
- Purity: ≥99.2% (HPLC verified)
- CAS Number: 2023788-19-2
- Appearance: Lyophilized white powder
- Category: Metabolic Research
Storage & Handling
- Storage: Store at 2–8°C, protected from light. Long-term: -20°C.
- Reconstitution: Reconstitute with 1 mL bacteriostatic water (0.9% benzyl alcohol).
- Shelf Life: 24 months unopened. 30 days reconstituted (refrigerated).
Purity & Third-Party Testing
Every batch of TIRZEPATIDE sourced by First Labs PH is independently analyzed by Janoshik Analytical for purity, identity, and content uniformity. HPLC and mass-spectrometry results are published openly on our Lab Reports page so researchers can match each vial to its certificate of analysis.
RESEARCH USE DISCLAIMER
This product is supplied for laboratory and research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Buyer must be 18 years of age or older and qualified to handle research compounds.
CUSTOMER REVIEWS
What researchers say
Loading reviews…
· EDUCATIONAL REFERENCE ·
Research Reference Quick Guide
FOR RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION
What is Tirzepatide?
Tirzepatide is a dual agonist peptide currently being studied for metabolic support, appetite regulation, weight management research, and glucose regulation research.
TARGETS
- · GLP-1
- · GIP receptors
Reconstitution Guide
SUGGESTED RECONSTITUTION
10mg Tirzepatide + 1mL Bacteriostatic Water
CONCENTRATION AFTER MIXING
2.5mg = 25 units on an insulin syringe
Research Dosing Format
ADMINISTRATION FREQUENCY
Once weekly
EXAMPLE RESEARCH ESCALATION STRUCTURE
| PHASE | WEEKLY AMOUNT |
|---|---|
| Weeks 1–4 | 2.5mg (25 units) |
| Weeks 5–8 | 5mg (50 units) |
| Weeks 9–12 | 7.5mg (75 units) |
| Weeks 13–16 | 10mg |
| Weeks 17+ | Up to 15mg maximum |
Dose escalation schedules used in studies vary depending on tolerance and research design.
Research Duration
EXAMPLE RESEARCH STRUCTURE
- · Commonly designed for continuous long-term evaluation
- · Escalation phases may vary depending on study response and tolerance
Storage
BEFORE RECONSTITUTION
- · Store in cool, dry place
- · Protect from heat and sunlight
AFTER RECONSTITUTION
- · Refrigerate at 2–8°C
- · Avoid shaking
- · Keep sterile
Commonly Reported Research Observations
- · Appetite suppression
- · Delayed gastric emptying
- · Nausea
- · Fatigue
- · Digestive discomfort
- · Bloating
IMPORTANT NOTES
- · Research compounds are not FDA approved for general human use.
- · Use sterile procedures during handling.
- · Monitor research response carefully during escalation phases.
- · Discontinue research if severe adverse effects occur.
FIRSTLABSPH
QUALITY · RESEARCH · TRANSPARENCY
QUESTIONS
Frequently Asked About TIRZEPATIDE
· YOU MAY ALSO LIKE ·
Related research compounds
METABOLIC RESEARCHOUT OF STOCKRETATRUTIDE
10MG
A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models. Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations. For laboratory research use only.
METABOLIC RESEARCHTIRZEPATIDE
20MG
A dual GIP and GLP-1 receptor agonist used as a reference compound in laboratory metabolic research. Research interest includes incretin-pathway studies, energy-balance research, glycemic-marker research models, and gastric-motility research. For laboratory research use only.
METABOLIC RESEARCHAOD-9604
5MG
A modified fragment of human growth hormone (hGH 176-191). Research interest includes lipolysis-pathway studies, lipid-metabolism research models, and cartilage research. For laboratory research use only.
GROWTH HORMONE RELEASINGIPAMORELIN
10MG
A selective pentapeptide growth-hormone secretagogue studied in laboratory research for its pulsatile release profile with minimal impact on cortisol, prolactin, or aldosterone. Research interest includes its role in GH-pathway studies, recovery-related research models, sleep-architecture studies, and connective-tissue research. For laboratory research use only.